4//SEC Filing
WAUNG FRANK 4
Accession 0001010549-10-000745
CIK 0001106644other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:37 PM ET
Size
10.7 KB
Accession
0001010549-10-000745
Insider Transaction Report
Form 4
WAUNG FRANK
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option
2010-11-15−40,000→ 260,000 totalExercise: $2.75From: 2010-04-28Exp: 2012-04-28→ Common Stock (4,052 underlying) - Exercise/Conversion
Common Stock
2010-11-15+4,052→ 6,552 total - Award
Stock Option
2010-04-28+200,000→ 300,000 totalExercise: $3.47From: 2011-04-28Exp: 2013-04-28→ Common Stock
Footnotes (3)
- [F1]The Reporting Person exercised his vested option to purchase 40,000 shares of common stock in a cashless manner pursuant to the 2009 Shares Option Agreement under the issuer's 2009 Stock Option Plan. The exercise was in a cashless manner, being the fair market value of the option of $3.06, the closing date on November 12, 2010, which led to the number of shares of common stock the Reporting Person received to be 4,052 shares.
- [F2]If exercising the option by cash, the underlying shares of common stock is 200,000; if cashless exercising the option, the underlying shares of common stock varies depending on the fair market value of the stock, i.e., the closing price on the date prior to the option exercise date.
- [F3]The stock option was granted to the Reporting Person as part of his compensation package for his services for the issuer in his capacity as the issuer's CFO that will vest as 150,000 shares of common stock on April 28, 2011. The remaining 50,000 shares of common stock will vest on April 28, 2011 but only if the issuer has consummated an offering of its securities at the minimum amount of $10 million by April 28, 2011.
Documents
Issuer
CHINA PHARMA HOLDINGS, INC.
CIK 0001106644
Entity typeother
Related Parties
1- filerCIK 0001470855
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 5:37 PM ET
- Size
- 10.7 KB